Browsing: balacovin phase 3 clinical trial

A Covid-19 drug manufactured by Kerala-based organization, PNB Vesper, has received nod by DCGI to conduct Phase 3 clinical trials. The organization will be conducting a nationwide multi-centred clinical trial of the drug- PNB-001 (GPP-BALACOVIN), on Covid-19 patients who are hospitalised and are on oxygen help.